nodes	percent_of_prediction	percent_of_DWPC	metapath
Atomoxetine—Propafenone—Salmeterol—asthma	0.245	1	CrCrCtD
Atomoxetine—CYP2D6—Ciclesonide—asthma	0.0205	0.0504	CbGbCtD
Atomoxetine—CYP2C19—Zafirlukast—asthma	0.0197	0.0484	CbGbCtD
Atomoxetine—CYP2C19—Arformoterol—asthma	0.019	0.0467	CbGbCtD
Atomoxetine—CYP2C19—Formoterol—asthma	0.019	0.0467	CbGbCtD
Atomoxetine—CYP2D6—Ipratropium bromide—asthma	0.017	0.0418	CbGbCtD
Atomoxetine—CYP3A4—Fluticasone furoate—asthma	0.016	0.0393	CbGbCtD
Atomoxetine—CYP2D6—Zafirlukast—asthma	0.015	0.0368	CbGbCtD
Atomoxetine—CYP2D6—Formoterol—asthma	0.0145	0.0355	CbGbCtD
Atomoxetine—CYP2D6—Arformoterol—asthma	0.0145	0.0355	CbGbCtD
Atomoxetine—CYP2C19—Loratadine—asthma	0.0144	0.0354	CbGbCtD
Atomoxetine—CYP3A4—Budesonide—asthma	0.0143	0.0351	CbGbCtD
Atomoxetine—CYP3A4—Indacaterol—asthma	0.0131	0.0321	CbGbCtD
Atomoxetine—CYP3A4—Ciclesonide—asthma	0.0131	0.0321	CbGbCtD
Atomoxetine—CYP2D6—Tiotropium—asthma	0.0129	0.0317	CbGbCtD
Atomoxetine—CYP3A4—Salmeterol—asthma	0.0121	0.0298	CbGbCtD
Atomoxetine—CYP3A4—Flunisolide—asthma	0.0121	0.0298	CbGbCtD
Atomoxetine—CYP3A4—Salbutamol—asthma	0.0121	0.0298	CbGbCtD
Atomoxetine—CYP2D6—Theophylline—asthma	0.0116	0.0284	CbGbCtD
Atomoxetine—CYP2D6—Loratadine—asthma	0.011	0.0269	CbGbCtD
Atomoxetine—CYP3A4—Zileuton—asthma	0.0108	0.0266	CbGbCtD
Atomoxetine—CYP3A4—Ipratropium bromide—asthma	0.0108	0.0266	CbGbCtD
Atomoxetine—CYP3A4—Fluticasone Propionate—asthma	0.0103	0.0254	CbGbCtD
Atomoxetine—CYP3A4—Zafirlukast—asthma	0.00953	0.0234	CbGbCtD
Atomoxetine—CYP3A4—Tiotropium—asthma	0.0082	0.0201	CbGbCtD
Atomoxetine—CYP2C19—Prednisone—asthma	0.00799	0.0196	CbGbCtD
Atomoxetine—CYP3A4—Aminophylline—asthma	0.00783	0.0192	CbGbCtD
Atomoxetine—CYP3A4—Theophylline—asthma	0.00736	0.0181	CbGbCtD
Atomoxetine—CYP3A4—Loratadine—asthma	0.00697	0.0171	CbGbCtD
Atomoxetine—CYP3A4—Montelukast—asthma	0.00697	0.0171	CbGbCtD
Atomoxetine—CYP3A4—Methylprednisolone—asthma	0.00638	0.0157	CbGbCtD
Atomoxetine—CYP2C19—Dexamethasone—asthma	0.00499	0.0123	CbGbCtD
Atomoxetine—CYP3A4—Triamcinolone—asthma	0.00483	0.0119	CbGbCtD
Atomoxetine—CYP3A4—Betamethasone—asthma	0.00415	0.0102	CbGbCtD
Atomoxetine—CYP3A4—Prednisolone—asthma	0.00409	0.01	CbGbCtD
Atomoxetine—CYP3A4—Hydrocortisone—asthma	0.00388	0.00953	CbGbCtD
Atomoxetine—CYP3A4—Prednisone—asthma	0.00386	0.00949	CbGbCtD
Atomoxetine—CYP2D6—Dexamethasone—asthma	0.00379	0.00932	CbGbCtD
Atomoxetine—CYP3A4—Dexamethasone—asthma	0.00241	0.00592	CbGbCtD
Atomoxetine—SLC6A2—autonomic nervous system—asthma	0.00217	0.148	CbGeAlD
Atomoxetine—HTR2A—vagus nerve—asthma	0.00188	0.128	CbGeAlD
Atomoxetine—NPY1R—adrenal cortex—asthma	0.00138	0.0942	CbGeAlD
Atomoxetine—HTR2A—autonomic nervous system—asthma	0.00131	0.089	CbGeAlD
Atomoxetine—NPY1R—adrenal gland—asthma	0.000997	0.068	CbGeAlD
Atomoxetine—NPY1R—lung—asthma	0.000874	0.0596	CbGeAlD
Atomoxetine—SLC6A3—respiratory system—asthma	0.000692	0.0472	CbGeAlD
Atomoxetine—SLC6A4—respiratory system—asthma	0.000635	0.0433	CbGeAlD
Atomoxetine—Pseudoephedrine—IL2—asthma	0.000588	0.233	CrCbGaD
Atomoxetine—SLC6A2—respiratory system—asthma	0.000559	0.0381	CbGeAlD
Atomoxetine—HTR1B—cardiovascular system—asthma	0.000535	0.0365	CbGeAlD
Atomoxetine—HTR1D—cardiovascular system—asthma	0.000518	0.0353	CbGeAlD
Atomoxetine—SLC6A3—lung—asthma	0.000368	0.0251	CbGeAlD
Atomoxetine—SLC6A2—adrenal gland—asthma	0.000338	0.0231	CbGeAlD
Atomoxetine—SLC6A4—lung—asthma	0.000337	0.023	CbGeAlD
Atomoxetine—HTR2A—respiratory system—asthma	0.000336	0.0229	CbGeAlD
Atomoxetine—SLC6A2—lung—asthma	0.000297	0.0202	CbGeAlD
Atomoxetine—HTR2A—epithelium—asthma	0.000281	0.0191	CbGeAlD
Atomoxetine—HTR2A—smooth muscle tissue—asthma	0.00027	0.0184	CbGeAlD
Atomoxetine—Ketoprofen—CXCL8—asthma	0.000262	0.104	CrCbGaD
Atomoxetine—HTR2A—cardiovascular system—asthma	0.000257	0.0175	CbGeAlD
Atomoxetine—HTR2A—trachea—asthma	0.000248	0.0169	CbGeAlD
Atomoxetine—Ephedrine—ADRB2—asthma	0.000232	0.0919	CrCbGaD
Atomoxetine—HTR2A—adrenal gland—asthma	0.000203	0.0139	CbGeAlD
Atomoxetine—Pseudoephedrine—TNF—asthma	0.000198	0.0786	CrCbGaD
Atomoxetine—HTR2A—lung—asthma	0.000178	0.0122	CbGeAlD
Atomoxetine—Pseudoephedrine—ADRB2—asthma	0.000176	0.0696	CrCbGaD
Atomoxetine—Fenoprofen—PTGS2—asthma	0.000129	0.0512	CrCbGaD
Atomoxetine—Phenoxybenzamine—ADRB2—asthma	0.000125	0.0496	CrCbGaD
Atomoxetine—Propranolol—ADRB2—asthma	0.000124	0.0489	CrCbGaD
Atomoxetine—Fenoprofen—ALB—asthma	0.000115	0.0456	CrCbGaD
Atomoxetine—Phenprocoumon—ALB—asthma	9.94e-05	0.0393	CrCbGaD
Atomoxetine—Fluoxetine—ALB—asthma	9.67e-05	0.0383	CrCbGaD
Atomoxetine—Desipramine—ADRB2—asthma	9.36e-05	0.037	CrCbGaD
Atomoxetine—Warfarin—ALB—asthma	8.82e-05	0.0349	CrCbGaD
Atomoxetine—Ketoprofen—PTGS2—asthma	7.64e-05	0.0302	CrCbGaD
Atomoxetine—Ketoprofen—ALB—asthma	6.8e-05	0.0269	CrCbGaD
Atomoxetine—Nortriptyline—ALB—asthma	5.43e-05	0.0215	CrCbGaD
Atomoxetine—Dizziness—Salbutamol—asthma	5.18e-05	0.000242	CcSEcCtD
Atomoxetine—Vomiting—Montelukast—asthma	5.16e-05	0.000241	CcSEcCtD
Atomoxetine—Rash—Montelukast—asthma	5.12e-05	0.000239	CcSEcCtD
Atomoxetine—Dermatitis—Montelukast—asthma	5.12e-05	0.000239	CcSEcCtD
Atomoxetine—Depression—Prednisone—asthma	5.1e-05	0.000238	CcSEcCtD
Atomoxetine—Headache—Montelukast—asthma	5.09e-05	0.000237	CcSEcCtD
Atomoxetine—Mental disorder—Methylprednisolone—asthma	5.08e-05	0.000237	CcSEcCtD
Atomoxetine—Malnutrition—Methylprednisolone—asthma	5.05e-05	0.000236	CcSEcCtD
Atomoxetine—Dizziness—Budesonide—asthma	5.02e-05	0.000234	CcSEcCtD
Atomoxetine—Vomiting—Salbutamol—asthma	4.98e-05	0.000232	CcSEcCtD
Atomoxetine—Dysgeusia—Triamcinolone—asthma	4.96e-05	0.000231	CcSEcCtD
Atomoxetine—Vertigo—Prednisolone—asthma	4.94e-05	0.000231	CcSEcCtD
Atomoxetine—Rash—Salbutamol—asthma	4.94e-05	0.00023	CcSEcCtD
Atomoxetine—Syncope—Prednisolone—asthma	4.94e-05	0.00023	CcSEcCtD
Atomoxetine—Dermatitis—Salbutamol—asthma	4.93e-05	0.00023	CcSEcCtD
Atomoxetine—Nausea—Arformoterol—asthma	4.93e-05	0.00023	CcSEcCtD
Atomoxetine—Nausea—Formoterol—asthma	4.93e-05	0.00023	CcSEcCtD
Atomoxetine—Headache—Salbutamol—asthma	4.91e-05	0.000229	CcSEcCtD
Atomoxetine—Back pain—Triamcinolone—asthma	4.9e-05	0.000228	CcSEcCtD
Atomoxetine—Loss of consciousness—Prednisolone—asthma	4.84e-05	0.000226	CcSEcCtD
Atomoxetine—Vertigo—Hydrocortisone—asthma	4.83e-05	0.000225	CcSEcCtD
Atomoxetine—Nausea—Montelukast—asthma	4.83e-05	0.000225	CcSEcCtD
Atomoxetine—Vomiting—Budesonide—asthma	4.82e-05	0.000225	CcSEcCtD
Atomoxetine—Syncope—Hydrocortisone—asthma	4.82e-05	0.000225	CcSEcCtD
Atomoxetine—Angiopathy—Dexamethasone—asthma	4.79e-05	0.000223	CcSEcCtD
Atomoxetine—Angiopathy—Betamethasone—asthma	4.79e-05	0.000223	CcSEcCtD
Atomoxetine—Rash—Budesonide—asthma	4.78e-05	0.000223	CcSEcCtD
Atomoxetine—Dermatitis—Budesonide—asthma	4.78e-05	0.000223	CcSEcCtD
Atomoxetine—Convulsion—Prednisolone—asthma	4.77e-05	0.000222	CcSEcCtD
Atomoxetine—Headache—Budesonide—asthma	4.75e-05	0.000222	CcSEcCtD
Atomoxetine—Loss of consciousness—Hydrocortisone—asthma	4.72e-05	0.00022	CcSEcCtD
Atomoxetine—Convulsion—Hydrocortisone—asthma	4.66e-05	0.000217	CcSEcCtD
Atomoxetine—Nausea—Salbutamol—asthma	4.65e-05	0.000217	CcSEcCtD
Atomoxetine—Myalgia—Hydrocortisone—asthma	4.58e-05	0.000214	CcSEcCtD
Atomoxetine—Hallucination—Prednisone—asthma	4.57e-05	0.000213	CcSEcCtD
Atomoxetine—Anxiety—Hydrocortisone—asthma	4.56e-05	0.000213	CcSEcCtD
Atomoxetine—Vertigo—Triamcinolone—asthma	4.55e-05	0.000212	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	4.54e-05	0.000212	CcSEcCtD
Atomoxetine—Syncope—Triamcinolone—asthma	4.54e-05	0.000212	CcSEcCtD
Atomoxetine—Vertigo—Methylprednisolone—asthma	4.54e-05	0.000212	CcSEcCtD
Atomoxetine—Syncope—Methylprednisolone—asthma	4.53e-05	0.000211	CcSEcCtD
Atomoxetine—Nausea—Budesonide—asthma	4.51e-05	0.00021	CcSEcCtD
Atomoxetine—Loss of consciousness—Triamcinolone—asthma	4.45e-05	0.000208	CcSEcCtD
Atomoxetine—Loss of consciousness—Methylprednisolone—asthma	4.44e-05	0.000207	CcSEcCtD
Atomoxetine—Shock—Prednisolone—asthma	4.42e-05	0.000206	CcSEcCtD
Atomoxetine—Cough—Triamcinolone—asthma	4.42e-05	0.000206	CcSEcCtD
Atomoxetine—Convulsion—Triamcinolone—asthma	4.38e-05	0.000205	CcSEcCtD
Atomoxetine—Tachycardia—Prednisolone—asthma	4.38e-05	0.000205	CcSEcCtD
Atomoxetine—Convulsion—Methylprednisolone—asthma	4.38e-05	0.000204	CcSEcCtD
Atomoxetine—Infection—Hydrocortisone—asthma	4.36e-05	0.000203	CcSEcCtD
Atomoxetine—Hyperhidrosis—Prednisolone—asthma	4.34e-05	0.000203	CcSEcCtD
Atomoxetine—Shock—Hydrocortisone—asthma	4.32e-05	0.000201	CcSEcCtD
Atomoxetine—Myalgia—Triamcinolone—asthma	4.31e-05	0.000201	CcSEcCtD
Atomoxetine—Nervous system disorder—Hydrocortisone—asthma	4.3e-05	0.000201	CcSEcCtD
Atomoxetine—Myalgia—Methylprednisolone—asthma	4.3e-05	0.000201	CcSEcCtD
Atomoxetine—Arthralgia—Methylprednisolone—asthma	4.3e-05	0.000201	CcSEcCtD
Atomoxetine—Anxiety—Methylprednisolone—asthma	4.28e-05	0.0002	CcSEcCtD
Atomoxetine—Tachycardia—Hydrocortisone—asthma	4.28e-05	0.0002	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	4.27e-05	0.000199	CcSEcCtD
Atomoxetine—Flushing—Prednisone—asthma	4.26e-05	0.000199	CcSEcCtD
Atomoxetine—Skin disorder—Hydrocortisone—asthma	4.26e-05	0.000199	CcSEcCtD
Atomoxetine—Hyperhidrosis—Hydrocortisone—asthma	4.24e-05	0.000198	CcSEcCtD
Atomoxetine—Dry mouth—Triamcinolone—asthma	4.21e-05	0.000197	CcSEcCtD
Atomoxetine—Anorexia—Hydrocortisone—asthma	4.18e-05	0.000195	CcSEcCtD
Atomoxetine—Angiopathy—Prednisone—asthma	4.17e-05	0.000194	CcSEcCtD
Atomoxetine—Vertigo—Dexamethasone—asthma	4.13e-05	0.000192	CcSEcCtD
Atomoxetine—Vertigo—Betamethasone—asthma	4.13e-05	0.000192	CcSEcCtD
Atomoxetine—Syncope—Betamethasone—asthma	4.12e-05	0.000192	CcSEcCtD
Atomoxetine—Syncope—Dexamethasone—asthma	4.12e-05	0.000192	CcSEcCtD
Atomoxetine—Infection—Triamcinolone—asthma	4.1e-05	0.000191	CcSEcCtD
Atomoxetine—Infection—Methylprednisolone—asthma	4.09e-05	0.000191	CcSEcCtD
Atomoxetine—Shock—Triamcinolone—asthma	4.06e-05	0.00019	CcSEcCtD
Atomoxetine—Insomnia—Prednisolone—asthma	4.06e-05	0.00019	CcSEcCtD
Atomoxetine—Shock—Methylprednisolone—asthma	4.05e-05	0.000189	CcSEcCtD
Atomoxetine—Nervous system disorder—Methylprednisolone—asthma	4.04e-05	0.000189	CcSEcCtD
Atomoxetine—Loss of consciousness—Dexamethasone—asthma	4.04e-05	0.000188	CcSEcCtD
Atomoxetine—Loss of consciousness—Betamethasone—asthma	4.04e-05	0.000188	CcSEcCtD
Atomoxetine—Paraesthesia—Prednisolone—asthma	4.03e-05	0.000188	CcSEcCtD
Atomoxetine—Tachycardia—Triamcinolone—asthma	4.03e-05	0.000188	CcSEcCtD
Atomoxetine—Mental disorder—Prednisone—asthma	4.02e-05	0.000188	CcSEcCtD
Atomoxetine—Tachycardia—Methylprednisolone—asthma	4.02e-05	0.000188	CcSEcCtD
Atomoxetine—Skin disorder—Methylprednisolone—asthma	4e-05	0.000187	CcSEcCtD
Atomoxetine—Malnutrition—Prednisone—asthma	4e-05	0.000187	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Hydrocortisone—asthma	4e-05	0.000186	CcSEcCtD
Atomoxetine—Hyperhidrosis—Triamcinolone—asthma	3.99e-05	0.000186	CcSEcCtD
Atomoxetine—Hyperhidrosis—Methylprednisolone—asthma	3.98e-05	0.000186	CcSEcCtD
Atomoxetine—Convulsion—Dexamethasone—asthma	3.98e-05	0.000186	CcSEcCtD
Atomoxetine—Convulsion—Betamethasone—asthma	3.98e-05	0.000186	CcSEcCtD
Atomoxetine—Insomnia—Hydrocortisone—asthma	3.97e-05	0.000185	CcSEcCtD
Atomoxetine—Paraesthesia—Hydrocortisone—asthma	3.94e-05	0.000184	CcSEcCtD
Atomoxetine—Myalgia—Dexamethasone—asthma	3.91e-05	0.000182	CcSEcCtD
Atomoxetine—Myalgia—Betamethasone—asthma	3.91e-05	0.000182	CcSEcCtD
Atomoxetine—Anxiety—Dexamethasone—asthma	3.9e-05	0.000182	CcSEcCtD
Atomoxetine—Anxiety—Betamethasone—asthma	3.9e-05	0.000182	CcSEcCtD
Atomoxetine—Dyspepsia—Hydrocortisone—asthma	3.86e-05	0.00018	CcSEcCtD
Atomoxetine—Pain—Prednisolone—asthma	3.84e-05	0.000179	CcSEcCtD
Atomoxetine—Decreased appetite—Hydrocortisone—asthma	3.81e-05	0.000178	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Hydrocortisone—asthma	3.79e-05	0.000177	CcSEcCtD
Atomoxetine—Fatigue—Hydrocortisone—asthma	3.78e-05	0.000176	CcSEcCtD
Atomoxetine—Vision blurred—Prednisone—asthma	3.77e-05	0.000176	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Triamcinolone—asthma	3.76e-05	0.000176	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Methylprednisolone—asthma	3.75e-05	0.000175	CcSEcCtD
Atomoxetine—Pain—Hydrocortisone—asthma	3.75e-05	0.000175	CcSEcCtD
Atomoxetine—Insomnia—Triamcinolone—asthma	3.74e-05	0.000174	CcSEcCtD
Atomoxetine—Insomnia—Methylprednisolone—asthma	3.73e-05	0.000174	CcSEcCtD
Atomoxetine—Infection—Dexamethasone—asthma	3.72e-05	0.000174	CcSEcCtD
Atomoxetine—Infection—Betamethasone—asthma	3.72e-05	0.000174	CcSEcCtD
Atomoxetine—Paraesthesia—Triamcinolone—asthma	3.71e-05	0.000173	CcSEcCtD
Atomoxetine—Feeling abnormal—Prednisolone—asthma	3.7e-05	0.000173	CcSEcCtD
Atomoxetine—Paraesthesia—Methylprednisolone—asthma	3.7e-05	0.000173	CcSEcCtD
Atomoxetine—Shock—Dexamethasone—asthma	3.69e-05	0.000172	CcSEcCtD
Atomoxetine—Shock—Betamethasone—asthma	3.69e-05	0.000172	CcSEcCtD
Atomoxetine—Nervous system disorder—Dexamethasone—asthma	3.68e-05	0.000171	CcSEcCtD
Atomoxetine—Nervous system disorder—Betamethasone—asthma	3.68e-05	0.000171	CcSEcCtD
Atomoxetine—Agitation—Prednisone—asthma	3.67e-05	0.000171	CcSEcCtD
Atomoxetine—Tachycardia—Dexamethasone—asthma	3.66e-05	0.000171	CcSEcCtD
Atomoxetine—Tachycardia—Betamethasone—asthma	3.66e-05	0.000171	CcSEcCtD
Atomoxetine—Dyspepsia—Triamcinolone—asthma	3.64e-05	0.00017	CcSEcCtD
Atomoxetine—Dyspepsia—Methylprednisolone—asthma	3.63e-05	0.000169	CcSEcCtD
Atomoxetine—Hyperhidrosis—Dexamethasone—asthma	3.62e-05	0.000169	CcSEcCtD
Atomoxetine—Hyperhidrosis—Betamethasone—asthma	3.62e-05	0.000169	CcSEcCtD
Atomoxetine—Feeling abnormal—Hydrocortisone—asthma	3.61e-05	0.000169	CcSEcCtD
Atomoxetine—Vertigo—Prednisone—asthma	3.59e-05	0.000168	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Hydrocortisone—asthma	3.59e-05	0.000167	CcSEcCtD
Atomoxetine—Syncope—Prednisone—asthma	3.59e-05	0.000167	CcSEcCtD
Atomoxetine—Anorexia—Betamethasone—asthma	3.57e-05	0.000167	CcSEcCtD
Atomoxetine—Anorexia—Dexamethasone—asthma	3.57e-05	0.000167	CcSEcCtD
Atomoxetine—Urticaria—Prednisolone—asthma	3.57e-05	0.000166	CcSEcCtD
Atomoxetine—Fatigue—Triamcinolone—asthma	3.56e-05	0.000166	CcSEcCtD
Atomoxetine—Fatigue—Methylprednisolone—asthma	3.55e-05	0.000166	CcSEcCtD
Atomoxetine—Pain—Triamcinolone—asthma	3.53e-05	0.000165	CcSEcCtD
Atomoxetine—Loss of consciousness—Prednisone—asthma	3.51e-05	0.000164	CcSEcCtD
Atomoxetine—Urticaria—Hydrocortisone—asthma	3.48e-05	0.000163	CcSEcCtD
Atomoxetine—Abdominal pain—Hydrocortisone—asthma	3.47e-05	0.000162	CcSEcCtD
Atomoxetine—Body temperature increased—Hydrocortisone—asthma	3.47e-05	0.000162	CcSEcCtD
Atomoxetine—Convulsion—Prednisone—asthma	3.46e-05	0.000162	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Dexamethasone—asthma	3.41e-05	0.000159	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Betamethasone—asthma	3.41e-05	0.000159	CcSEcCtD
Atomoxetine—Arthralgia—Prednisone—asthma	3.4e-05	0.000159	CcSEcCtD
Atomoxetine—Myalgia—Prednisone—asthma	3.4e-05	0.000159	CcSEcCtD
Atomoxetine—Feeling abnormal—Triamcinolone—asthma	3.4e-05	0.000159	CcSEcCtD
Atomoxetine—Feeling abnormal—Methylprednisolone—asthma	3.4e-05	0.000158	CcSEcCtD
Atomoxetine—Anxiety—Prednisone—asthma	3.39e-05	0.000158	CcSEcCtD
Atomoxetine—Insomnia—Betamethasone—asthma	3.39e-05	0.000158	CcSEcCtD
Atomoxetine—Insomnia—Dexamethasone—asthma	3.39e-05	0.000158	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	3.38e-05	0.000158	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Methylprednisolone—asthma	3.37e-05	0.000157	CcSEcCtD
Atomoxetine—Paraesthesia—Betamethasone—asthma	3.37e-05	0.000157	CcSEcCtD
Atomoxetine—Paraesthesia—Dexamethasone—asthma	3.37e-05	0.000157	CcSEcCtD
Atomoxetine—Dyspepsia—Betamethasone—asthma	3.3e-05	0.000154	CcSEcCtD
Atomoxetine—Dyspepsia—Dexamethasone—asthma	3.3e-05	0.000154	CcSEcCtD
Atomoxetine—Urticaria—Triamcinolone—asthma	3.28e-05	0.000153	CcSEcCtD
Atomoxetine—Urticaria—Methylprednisolone—asthma	3.27e-05	0.000153	CcSEcCtD
Atomoxetine—Body temperature increased—Triamcinolone—asthma	3.27e-05	0.000152	CcSEcCtD
Atomoxetine—Abdominal pain—Methylprednisolone—asthma	3.26e-05	0.000152	CcSEcCtD
Atomoxetine—Decreased appetite—Betamethasone—asthma	3.26e-05	0.000152	CcSEcCtD
Atomoxetine—Decreased appetite—Dexamethasone—asthma	3.26e-05	0.000152	CcSEcCtD
Atomoxetine—Infection—Prednisone—asthma	3.24e-05	0.000151	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Dexamethasone—asthma	3.24e-05	0.000151	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Betamethasone—asthma	3.24e-05	0.000151	CcSEcCtD
Atomoxetine—Fatigue—Dexamethasone—asthma	3.23e-05	0.000151	CcSEcCtD
Atomoxetine—Fatigue—Betamethasone—asthma	3.23e-05	0.000151	CcSEcCtD
Atomoxetine—Shock—Prednisone—asthma	3.21e-05	0.00015	CcSEcCtD
Atomoxetine—Pain—Betamethasone—asthma	3.2e-05	0.00015	CcSEcCtD
Atomoxetine—Pain—Dexamethasone—asthma	3.2e-05	0.00015	CcSEcCtD
Atomoxetine—Nervous system disorder—Prednisone—asthma	3.2e-05	0.000149	CcSEcCtD
Atomoxetine—Tachycardia—Prednisone—asthma	3.19e-05	0.000149	CcSEcCtD
Atomoxetine—Skin disorder—Prednisone—asthma	3.17e-05	0.000148	CcSEcCtD
Atomoxetine—Hyperhidrosis—Prednisone—asthma	3.16e-05	0.000147	CcSEcCtD
Atomoxetine—Asthenia—Hydrocortisone—asthma	3.15e-05	0.000147	CcSEcCtD
Atomoxetine—Anorexia—Prednisone—asthma	3.11e-05	0.000145	CcSEcCtD
Atomoxetine—Pruritus—Hydrocortisone—asthma	3.1e-05	0.000145	CcSEcCtD
Atomoxetine—Feeling abnormal—Dexamethasone—asthma	3.09e-05	0.000144	CcSEcCtD
Atomoxetine—Feeling abnormal—Betamethasone—asthma	3.09e-05	0.000144	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Betamethasone—asthma	3.06e-05	0.000143	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Dexamethasone—asthma	3.06e-05	0.000143	CcSEcCtD
Atomoxetine—Diarrhoea—Hydrocortisone—asthma	3e-05	0.00014	CcSEcCtD
Atomoxetine—Urticaria—Dexamethasone—asthma	2.98e-05	0.000139	CcSEcCtD
Atomoxetine—Urticaria—Betamethasone—asthma	2.98e-05	0.000139	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Prednisone—asthma	2.97e-05	0.000139	CcSEcCtD
Atomoxetine—Dizziness—Prednisolone—asthma	2.97e-05	0.000139	CcSEcCtD
Atomoxetine—Asthenia—Triamcinolone—asthma	2.96e-05	0.000138	CcSEcCtD
Atomoxetine—Body temperature increased—Betamethasone—asthma	2.96e-05	0.000138	CcSEcCtD
Atomoxetine—Body temperature increased—Dexamethasone—asthma	2.96e-05	0.000138	CcSEcCtD
Atomoxetine—Abdominal pain—Betamethasone—asthma	2.96e-05	0.000138	CcSEcCtD
Atomoxetine—Abdominal pain—Dexamethasone—asthma	2.96e-05	0.000138	CcSEcCtD
Atomoxetine—Asthenia—Methylprednisolone—asthma	2.96e-05	0.000138	CcSEcCtD
Atomoxetine—Insomnia—Prednisone—asthma	2.95e-05	0.000138	CcSEcCtD
Atomoxetine—Paraesthesia—Prednisone—asthma	2.93e-05	0.000137	CcSEcCtD
Atomoxetine—Pruritus—Triamcinolone—asthma	2.92e-05	0.000136	CcSEcCtD
Atomoxetine—Pruritus—Methylprednisolone—asthma	2.92e-05	0.000136	CcSEcCtD
Atomoxetine—Dizziness—Hydrocortisone—asthma	2.9e-05	0.000135	CcSEcCtD
Atomoxetine—Dyspepsia—Prednisone—asthma	2.87e-05	0.000134	CcSEcCtD
Atomoxetine—Decreased appetite—Prednisone—asthma	2.84e-05	0.000132	CcSEcCtD
Atomoxetine—Rash—Prednisolone—asthma	2.83e-05	0.000132	CcSEcCtD
Atomoxetine—Dermatitis—Prednisolone—asthma	2.83e-05	0.000132	CcSEcCtD
Atomoxetine—Diarrhoea—Methylprednisolone—asthma	2.82e-05	0.000132	CcSEcCtD
Atomoxetine—Fatigue—Prednisone—asthma	2.81e-05	0.000131	CcSEcCtD
Atomoxetine—Headache—Prednisolone—asthma	2.81e-05	0.000131	CcSEcCtD
Atomoxetine—Constipation—Prednisone—asthma	2.79e-05	0.00013	CcSEcCtD
Atomoxetine—Vomiting—Hydrocortisone—asthma	2.79e-05	0.00013	CcSEcCtD
Atomoxetine—Rash—Hydrocortisone—asthma	2.77e-05	0.000129	CcSEcCtD
Atomoxetine—Dermatitis—Hydrocortisone—asthma	2.76e-05	0.000129	CcSEcCtD
Atomoxetine—Headache—Hydrocortisone—asthma	2.75e-05	0.000128	CcSEcCtD
Atomoxetine—Dizziness—Triamcinolone—asthma	2.73e-05	0.000127	CcSEcCtD
Atomoxetine—Dizziness—Methylprednisolone—asthma	2.73e-05	0.000127	CcSEcCtD
Atomoxetine—Feeling abnormal—Prednisone—asthma	2.69e-05	0.000125	CcSEcCtD
Atomoxetine—Asthenia—Dexamethasone—asthma	2.69e-05	0.000125	CcSEcCtD
Atomoxetine—Asthenia—Betamethasone—asthma	2.69e-05	0.000125	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Prednisone—asthma	2.67e-05	0.000125	CcSEcCtD
Atomoxetine—Nausea—Prednisolone—asthma	2.67e-05	0.000124	CcSEcCtD
Atomoxetine—Pruritus—Dexamethasone—asthma	2.65e-05	0.000124	CcSEcCtD
Atomoxetine—Pruritus—Betamethasone—asthma	2.65e-05	0.000124	CcSEcCtD
Atomoxetine—Vomiting—Triamcinolone—asthma	2.63e-05	0.000123	CcSEcCtD
Atomoxetine—Vomiting—Methylprednisolone—asthma	2.62e-05	0.000122	CcSEcCtD
Atomoxetine—Nausea—Hydrocortisone—asthma	2.61e-05	0.000122	CcSEcCtD
Atomoxetine—Rash—Triamcinolone—asthma	2.6e-05	0.000122	CcSEcCtD
Atomoxetine—Dermatitis—Triamcinolone—asthma	2.6e-05	0.000121	CcSEcCtD
Atomoxetine—Rash—Methylprednisolone—asthma	2.6e-05	0.000121	CcSEcCtD
Atomoxetine—Dermatitis—Methylprednisolone—asthma	2.6e-05	0.000121	CcSEcCtD
Atomoxetine—Urticaria—Prednisone—asthma	2.59e-05	0.000121	CcSEcCtD
Atomoxetine—Headache—Triamcinolone—asthma	2.59e-05	0.000121	CcSEcCtD
Atomoxetine—Headache—Methylprednisolone—asthma	2.58e-05	0.00012	CcSEcCtD
Atomoxetine—Abdominal pain—Prednisone—asthma	2.58e-05	0.00012	CcSEcCtD
Atomoxetine—Body temperature increased—Prednisone—asthma	2.58e-05	0.00012	CcSEcCtD
Atomoxetine—Diarrhoea—Dexamethasone—asthma	2.56e-05	0.00012	CcSEcCtD
Atomoxetine—Diarrhoea—Betamethasone—asthma	2.56e-05	0.00012	CcSEcCtD
Atomoxetine—Dizziness—Dexamethasone—asthma	2.48e-05	0.000116	CcSEcCtD
Atomoxetine—Dizziness—Betamethasone—asthma	2.48e-05	0.000116	CcSEcCtD
Atomoxetine—Nausea—Triamcinolone—asthma	2.45e-05	0.000114	CcSEcCtD
Atomoxetine—Nausea—Methylprednisolone—asthma	2.45e-05	0.000114	CcSEcCtD
Atomoxetine—Vomiting—Betamethasone—asthma	2.38e-05	0.000111	CcSEcCtD
Atomoxetine—Vomiting—Dexamethasone—asthma	2.38e-05	0.000111	CcSEcCtD
Atomoxetine—Rash—Dexamethasone—asthma	2.36e-05	0.00011	CcSEcCtD
Atomoxetine—Rash—Betamethasone—asthma	2.36e-05	0.00011	CcSEcCtD
Atomoxetine—Dermatitis—Dexamethasone—asthma	2.36e-05	0.00011	CcSEcCtD
Atomoxetine—Dermatitis—Betamethasone—asthma	2.36e-05	0.00011	CcSEcCtD
Atomoxetine—Headache—Dexamethasone—asthma	2.35e-05	0.00011	CcSEcCtD
Atomoxetine—Headache—Betamethasone—asthma	2.35e-05	0.00011	CcSEcCtD
Atomoxetine—Asthenia—Prednisone—asthma	2.34e-05	0.000109	CcSEcCtD
Atomoxetine—Pruritus—Prednisone—asthma	2.31e-05	0.000108	CcSEcCtD
Atomoxetine—Diarrhoea—Prednisone—asthma	2.23e-05	0.000104	CcSEcCtD
Atomoxetine—Nausea—Dexamethasone—asthma	2.23e-05	0.000104	CcSEcCtD
Atomoxetine—Nausea—Betamethasone—asthma	2.23e-05	0.000104	CcSEcCtD
Atomoxetine—Dizziness—Prednisone—asthma	2.16e-05	0.000101	CcSEcCtD
Atomoxetine—Vomiting—Prednisone—asthma	2.08e-05	9.68e-05	CcSEcCtD
Atomoxetine—Rash—Prednisone—asthma	2.06e-05	9.6e-05	CcSEcCtD
Atomoxetine—Dermatitis—Prednisone—asthma	2.06e-05	9.59e-05	CcSEcCtD
Atomoxetine—Headache—Prednisone—asthma	2.04e-05	9.54e-05	CcSEcCtD
Atomoxetine—Nausea—Prednisone—asthma	1.94e-05	9.05e-05	CcSEcCtD
Atomoxetine—HTR2A—Signaling Pathways—NPS—asthma	7.55e-06	6.51e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—TAC1—asthma	7.55e-06	6.51e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—ADCY2—asthma	7.55e-06	6.5e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—IL3—asthma	7.52e-06	6.48e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—SMAD3—asthma	7.51e-06	6.47e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—CXCL8—asthma	7.43e-06	6.4e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CXCR3—asthma	7.41e-06	6.38e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—PPP2CA—asthma	7.39e-06	6.37e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—CXCL8—asthma	7.37e-06	6.35e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—CHAT—asthma	7.37e-06	6.35e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—PPP2CA—asthma	7.34e-06	6.32e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CCR5—asthma	7.26e-06	6.26e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—CXCL8—asthma	7.22e-06	6.22e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CCR5—asthma	7.2e-06	6.21e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—PPP2CA—asthma	7.18e-06	6.19e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CYBA—asthma	7.17e-06	6.18e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—IL2RA—asthma	7.15e-06	6.17e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—ALOX5—asthma	7.14e-06	6.15e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—IL2—asthma	7.1e-06	6.12e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—IL2RA—asthma	7.1e-06	6.12e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—KNG1—asthma	7.1e-06	6.12e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—C3—asthma	7.09e-06	6.11e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—POMC—asthma	7.07e-06	6.1e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CCR5—asthma	7.05e-06	6.08e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—AGTR1—asthma	7.05e-06	6.08e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—IL2—asthma	7.05e-06	6.07e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—C3—asthma	7.04e-06	6.07e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—ARG1—asthma	7.03e-06	6.06e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—PARP1—asthma	7.02e-06	6.05e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—IL5—asthma	7.02e-06	6.05e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—IL2RA—asthma	6.95e-06	5.99e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—CCL2—asthma	6.92e-06	5.96e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—PDGFB—asthma	6.91e-06	5.95e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—IL6R—asthma	6.9e-06	5.95e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—IL2—asthma	6.9e-06	5.95e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—C3—asthma	6.89e-06	5.94e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CXCL10—asthma	6.89e-06	5.94e-05	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—RHOA—asthma	6.86e-06	5.91e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—PDGFB—asthma	6.85e-06	5.91e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—CARM1—asthma	6.81e-06	5.87e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—BDKRB2—asthma	6.77e-06	5.84e-05	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—POMC—asthma	6.76e-06	5.83e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—NTRK1—asthma	6.76e-06	5.83e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—DCN—asthma	6.71e-06	5.79e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—PDGFB—asthma	6.71e-06	5.78e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—ADRB2—asthma	6.69e-06	5.77e-05	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—IL6—asthma	6.68e-06	5.76e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—LEP—asthma	6.6e-06	5.69e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—ALOX5—asthma	6.57e-06	5.66e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—LEP—asthma	6.55e-06	5.65e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—ADCY2—asthma	6.55e-06	5.65e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—IL3—asthma	6.53e-06	5.63e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—ALDH2—asthma	6.53e-06	5.63e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—LEP—asthma	6.42e-06	5.53e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—ALDH7A1—asthma	6.36e-06	5.48e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—ITPR1—asthma	6.33e-06	5.46e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—asthma	6.28e-06	5.41e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—CARM1—asthma	6.27e-06	5.4e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—RHOA—asthma	6.23e-06	5.37e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—FN1—asthma	6.23e-06	5.37e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—GSTT1—asthma	6.21e-06	5.35e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—FN1—asthma	6.18e-06	5.33e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—DCN—asthma	6.18e-06	5.32e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—KNG1—asthma	6.16e-06	5.31e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—POMC—asthma	6.14e-06	5.29e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—AGTR1—asthma	6.13e-06	5.28e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—ARG2—asthma	6.1e-06	5.25e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—FN1—asthma	6.05e-06	5.22e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CD86—asthma	6.03e-06	5.2e-05	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—CXCL8—asthma	6.03e-06	5.19e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—CCL2—asthma	6.01e-06	5.18e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—ALDH2—asthma	6.01e-06	5.18e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—IL6R—asthma	5.99e-06	5.16e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CXCL10—asthma	5.99e-06	5.16e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—EDN1—asthma	5.98e-06	5.15e-05	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—RHOA—asthma	5.96e-06	5.14e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CCL5—asthma	5.93e-06	5.11e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—PLA2G4A—asthma	5.91e-06	5.09e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—NTRK1—asthma	5.87e-06	5.06e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CSF2—asthma	5.85e-06	5.04e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—ADRB2—asthma	5.81e-06	5.01e-05	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—IL2—asthma	5.76e-06	4.96e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—asthma	5.73e-06	4.93e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—GSTT1—asthma	5.71e-06	4.92e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—SMAD3—asthma	5.69e-06	4.9e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—POMC—asthma	5.67e-06	4.89e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—POMC—asthma	5.63e-06	4.85e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CCL2—asthma	5.55e-06	4.78e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—IL6R—asthma	5.53e-06	4.77e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—POMC—asthma	5.51e-06	4.75e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CCL2—asthma	5.51e-06	4.75e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—ITPR1—asthma	5.5e-06	4.74e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—IL6R—asthma	5.49e-06	4.73e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—CXCL8—asthma	5.47e-06	4.72e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—PPP2CA—asthma	5.44e-06	4.69e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—EGFR—asthma	5.43e-06	4.68e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—RHOA—asthma	5.41e-06	4.66e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CCL2—asthma	5.39e-06	4.65e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—EGFR—asthma	5.39e-06	4.64e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—IL6R—asthma	5.38e-06	4.64e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CCR5—asthma	5.35e-06	4.61e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—EGFR—asthma	5.28e-06	4.55e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—IL2RA—asthma	5.27e-06	4.54e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CD86—asthma	5.23e-06	4.51e-05	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—CXCL8—asthma	5.23e-06	4.51e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—IL2—asthma	5.23e-06	4.51e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—C3—asthma	5.22e-06	4.5e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—EDN1—asthma	5.19e-06	4.48e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—SERPINE1—asthma	5.18e-06	4.47e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—NQO1—asthma	5.16e-06	4.45e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CCL5—asthma	5.15e-06	4.44e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—SERPINE1—asthma	5.14e-06	4.43e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—PLA2G4A—asthma	5.13e-06	4.42e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—PDGFB—asthma	5.09e-06	4.38e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CSF2—asthma	5.08e-06	4.37e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—ADCY2—asthma	5.05e-06	4.35e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—ALOX5AP—asthma	5.05e-06	4.35e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—ALOX15—asthma	5.05e-06	4.35e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—SERPINE1—asthma	5.04e-06	4.34e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—asthma	5.01e-06	4.32e-05	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—IL2—asthma	5e-06	4.31e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—RHOA—asthma	5e-06	4.31e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—RHOA—asthma	4.96e-06	4.28e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—NOS3—asthma	4.95e-06	4.26e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—SMAD3—asthma	4.94e-06	4.26e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—NOS3—asthma	4.91e-06	4.23e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—LEP—asthma	4.86e-06	4.19e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—RHOA—asthma	4.86e-06	4.19e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—CHAT—asthma	4.82e-06	4.15e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—NOS3—asthma	4.81e-06	4.14e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—CXCL8—asthma	4.75e-06	4.09e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—NQO1—asthma	4.75e-06	4.09e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—PPP2CA—asthma	4.73e-06	4.07e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—ADCY2—asthma	4.65e-06	4e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CCR5—asthma	4.64e-06	4e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—FN1—asthma	4.59e-06	3.95e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—IL2RA—asthma	4.58e-06	3.94e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—IL2—asthma	4.54e-06	3.91e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—C3—asthma	4.54e-06	3.91e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—PDGFB—asthma	4.42e-06	3.81e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CXCL8—asthma	4.39e-06	3.78e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—asthma	4.37e-06	3.76e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CXCL8—asthma	4.36e-06	3.75e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—GSTP1—asthma	4.31e-06	3.71e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—ALOX5—asthma	4.29e-06	3.7e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CXCL8—asthma	4.26e-06	3.68e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—HMOX1—asthma	4.25e-06	3.66e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—ITPR1—asthma	4.24e-06	3.65e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—LEP—asthma	4.22e-06	3.64e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—IL2—asthma	4.19e-06	3.61e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—CAT—asthma	4.19e-06	3.61e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—POMC—asthma	4.18e-06	3.6e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—IL6—asthma	4.17e-06	3.6e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—IL2—asthma	4.16e-06	3.59e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—IL6—asthma	4.14e-06	3.57e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—CARM1—asthma	4.1e-06	3.53e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CCL2—asthma	4.09e-06	3.52e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—IL6R—asthma	4.08e-06	3.51e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—IL2—asthma	4.08e-06	3.51e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—IL6—asthma	4.06e-06	3.5e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—DCN—asthma	4.04e-06	3.48e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—EGFR—asthma	4e-06	3.45e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—FN1—asthma	3.98e-06	3.43e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—MMP9—asthma	3.97e-06	3.42e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—GSTP1—asthma	3.96e-06	3.41e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—PLA2G4A—asthma	3.96e-06	3.41e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—GSTM1—asthma	3.96e-06	3.41e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—PTEN—asthma	3.95e-06	3.4e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—MMP9—asthma	3.94e-06	3.4e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—ALDH2—asthma	3.93e-06	3.38e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—PTEN—asthma	3.92e-06	3.38e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—HMOX1—asthma	3.91e-06	3.37e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—ITPR1—asthma	3.9e-06	3.36e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—MMP9—asthma	3.86e-06	3.32e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—CAT—asthma	3.85e-06	3.32e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—PTEN—asthma	3.84e-06	3.31e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—SERPINE1—asthma	3.82e-06	3.29e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—GSTT1—asthma	3.74e-06	3.22e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—RHOA—asthma	3.68e-06	3.17e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—PPP2CA—asthma	3.64e-06	3.14e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—NOS3—asthma	3.64e-06	3.14e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—PLA2G4A—asthma	3.64e-06	3.14e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—GSTM1—asthma	3.64e-06	3.14e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—POMC—asthma	3.63e-06	3.13e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—VEGFA—asthma	3.56e-06	3.07e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CCL2—asthma	3.55e-06	3.06e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—IL6R—asthma	3.54e-06	3.05e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—VEGFA—asthma	3.54e-06	3.05e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—STAT3—asthma	3.53e-06	3.04e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—STAT3—asthma	3.5e-06	3.02e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—EGFR—asthma	3.47e-06	2.99e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—VEGFA—asthma	3.46e-06	2.99e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—STAT3—asthma	3.43e-06	2.96e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—PPP2CA—asthma	3.35e-06	2.89e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—SERPINE1—asthma	3.31e-06	2.86e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—TGFB1—asthma	3.27e-06	2.82e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—TGFB1—asthma	3.25e-06	2.8e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CXCL8—asthma	3.23e-06	2.79e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—EGFR—asthma	3.21e-06	2.76e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—RHOA—asthma	3.2e-06	2.76e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—EGFR—asthma	3.18e-06	2.74e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—TGFB1—asthma	3.18e-06	2.74e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—NOS3—asthma	3.16e-06	2.73e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—EGFR—asthma	3.12e-06	2.69e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—NQO1—asthma	3.1e-06	2.68e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—IL2—asthma	3.09e-06	2.66e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—IL6—asthma	3.07e-06	2.65e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—ADCY2—asthma	3.04e-06	2.62e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—MMP9—asthma	2.92e-06	2.52e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—PTEN—asthma	2.91e-06	2.5e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CXCL8—asthma	2.81e-06	2.42e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—POMC—asthma	2.8e-06	2.41e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—IL2—asthma	2.68e-06	2.31e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—IL6—asthma	2.67e-06	2.3e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—VEGFA—asthma	2.63e-06	2.26e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—STAT3—asthma	2.6e-06	2.24e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—GSTP1—asthma	2.59e-06	2.23e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—POMC—asthma	2.57e-06	2.22e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—HMOX1—asthma	2.55e-06	2.2e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—ALB—asthma	2.55e-06	2.2e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—ITPR1—asthma	2.55e-06	2.2e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—MMP9—asthma	2.54e-06	2.19e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—PTEN—asthma	2.52e-06	2.18e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—CAT—asthma	2.52e-06	2.17e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—IL6—asthma	2.47e-06	2.12e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—IL6—asthma	2.45e-06	2.11e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—NOS3—asthma	2.44e-06	2.1e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—TGFB1—asthma	2.41e-06	2.08e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—IL6—asthma	2.4e-06	2.06e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—PLA2G4A—asthma	2.38e-06	2.05e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—GSTM1—asthma	2.38e-06	2.05e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—EGFR—asthma	2.36e-06	2.04e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—ALB—asthma	2.35e-06	2.02e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—VEGFA—asthma	2.28e-06	1.96e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—STAT3—asthma	2.26e-06	1.95e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—NOS3—asthma	2.24e-06	1.93e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—PTGS2—asthma	2.23e-06	1.92e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—PPP2CA—asthma	2.19e-06	1.89e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—TGFB1—asthma	2.09e-06	1.8e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—PTGS2—asthma	2.05e-06	1.77e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—EGFR—asthma	2.05e-06	1.77e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—PTEN—asthma	1.95e-06	1.68e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—IL6—asthma	1.82e-06	1.56e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—PTEN—asthma	1.79e-06	1.54e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—POMC—asthma	1.68e-06	1.45e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—IL6—asthma	1.58e-06	1.36e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—ALB—asthma	1.53e-06	1.32e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—NOS3—asthma	1.47e-06	1.26e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—PTGS2—asthma	1.34e-06	1.16e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—PTEN—asthma	1.17e-06	1.01e-05	CbGpPWpGaD
